Editor Note to article entitled “The assessment of reservoir potential of Permian to Eocene reservoirs of Minwal-Joyamair fields, upper Indus basin, Pakistan” [Heliyon 9 (2023) e16517]

The MOBILIsE project is an ERA-CHAIR initiative at the Institute for Research and Innovation in Health (i3S, University of Porto) funded by the EU H2020 program and focused on molecular bioengineering to underpin and advance innovative therapies for benefiting human health. Immunoengineering, the ability to modulate host immunity through engineered therapeutics (molecules, biomaterials, and cells), has been pivotal for development of immunotherapies. From June 16 to 18, 2025, i3S hosted the first symposium of the MOBILIsE project on "Immunoengineering: from molecules to biomaterials and cell therapies." It brought bioengineers exploring biomolecular engineering tools and techniques to manipulate immune function for clinical translation in cancer, infection, and regenerative medicine. This Voices article mirrors the excellent contributions from speakers and participants on current trends and challenges in immunoengineering and in the development of immunotherapies (from bench to bedside), as well as the enthusiasm of the organizers and hosts of the MOBILIsE symposium.